Commitments and Contingencies - Schedule of Milestone Payment (Details) |
Dec. 31, 2023
USD ($)
|
|---|---|
| Revenue Recognition Milestone Method [Line Items] | |
| Total potential milestone payments | $ 5,625,000 |
| First Dosing of Patient In U S Phase1 Trial | |
| Revenue Recognition Milestone Method [Line Items] | |
| Total potential milestone payments | 250,000 |
| US Phase 1 Trial Completion with Endpoints Met | |
| Revenue Recognition Milestone Method [Line Items] | |
| Total potential milestone payments | 500,000 |
| US Phase 2 Trial Completion with Endpoints Met | |
| Revenue Recognition Milestone Method [Line Items] | |
| Total potential milestone payments | 875,000 |
| FDA Approval | |
| Revenue Recognition Milestone Method [Line Items] | |
| Total potential milestone payments | $ 4,000,000 |
| X | ||||||||||
- Definition Total potential milestone payments. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|